381 results on '"Hoffman, Stephen L"'
Search Results
2. Immune responses associated with protection induced by chemoattenuated PfSPZ vaccine in malaria-naive Europeans
3. Innate immune activation restricts priming and protective efficacy of the radiation-attenuated PfSPZ malaria vaccine
4. Implementation of a Randomized, Placebo-Controlled Trial of Live Attenuated Malaria Sporozoite Vaccines in an Indonesian Military Study Population
5. Ultra-low volume intradermal administration of radiation-attenuated sporozoites with the glycolipid adjuvant 7DW8-5 completely protects mice against malaria
6. Safety and protective efficacy of PfSPZ Vaccine administered to HIV-negative and -positive Tanzanian adults
7. Plasmodium knowlesi in pig-tailed macaques: a potential new model for malaria vaccine research
8. OA-722 Assessment of naturally acquired humoral immunity against malaria protecting against controlled human malaria infection (CHMI)
9. Ultra-low volume intradermal administration of radiation-attenuated sporozoites with the glycolipid adjuvant 7DW8-5 completely protects mice against malaria
10. Preliminary studies on the immunogenicity of a prime-and-trap malaria vaccine in nonhuman primates
11. Safety and Immunogenicity of Radiation-Attenuated PfSPZ Vaccine in Equatoguinean Infants, Children, and Adults
12. The exception that proves the rule: Virulence gene expression at the onset of Plasmodium falciparum blood stage infections
13. Molecular and functional properties of human Plasmodium falciparum CSP C‐terminus antibodies
14. Plasmodium 18S rRNA biomarker clearance after FDA-approved antimalarial treatment in controlled human malaria infection trials
15. Molecular and functional properties of humanPlasmodium falciparumCSP C-terminus antibodies
16. Sex-Specific Differences in Cytokine Induction by the Glycolipid Adjuvant 7DW8-5 in Mice
17. In vitro production of infectious Plasmodium falciparum sporozoites
18. A randomized controlled trial showing safety and efficacy of a whole sporozoite vaccine against endemic malaria
19. The exception that proves the rule: Virulence gene expression at the onset ofPlasmodium falciparumblood stage infections
20. Increased levels of anti-PfCSP antibodies in post-pubertal females versus males immunized with PfSPZ Vaccine does not translate into increased protective efficacy
21. PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial
22. Efficient infection of non-human primates with purified, cryopreserved Plasmodium knowlesi sporozoites
23. A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection
24. Immunological profiles associated with distinct parasitemic states in volunteers undergoing malaria challenge in Gabon
25. Cellular and antibody response in GMZ2-vaccinated Gabonese volunteers in a controlled human malaria infection trial
26. Plasmodium falciparum 7G8 challenge provides conservative prediction of efficacy of PfNF54-based PfSPZ Vaccine in Africa
27. Clonal evolution and TCR specificity of the human TFHcell response toPlasmodium falciparumCSP
28. Efficacy, T cell activation and antibody responses in accelerated Plasmodium falciparum sporozoite chemoprophylaxis vaccine regimens
29. The impact of Loa loa microfilaraemia on research subject retention during a whole sporozoite malaria vaccine trial in Equatorial Guinea
30. Cryopreserved Sporozoites with and without the Glycolipid Adjuvant 7DW8-5 Protect in Prime-and-Trap Malaria Vaccination
31. Multi-Dose Priming Regimens of PfSPZ Vaccine: Safety and Efficacy against Controlled Human Malaria Infection in Equatoguinean Adults
32. Diagnostic performance and comparison of ultrasensitive and conventional rapid diagnostic test, thick blood smear and quantitative PCR for detection of low-density Plasmodium falciparum infections during a controlled human malaria infection study in Equatorial Guinea
33. Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial
34. A First for Human Vaccinology: GMP Compliant Radiation Attenuation of Plasmodium falciparum Sporozoites for Production of a Vaccine Against Malaria
35. Cryopreservation of Anopheles stephensi embryos
36. Genome, proteome, and immunome data explain why 6 month controlled human malaria infection with sporozoites of the Pf7G8 clone of Plasmodium falciparum is a rigorous predictor of the efficacy of the PfNF54-based PfSPZ Vaccine in Africa
37. Diagnostic Performance and Comparison of Ultrasensitive and Conventional Rapid Diagnostic Test, Thick Blood Smear and Quantitative PCR for Detection of Low-Density Plasmodium Falciparum Infections During a Controlled Human Malaria Infection Study in Equatorial Guinea
38. Knockout of Anopheles stephensi immune gene LRIM1 by CRISPR-Cas9 reveals its unexpected role in reproduction and vector competence
39. An efficient single‐cell based method for linking human T cell phenotype to T cell receptor sequence and specificity
40. Innate immune activation restricts priming and protective efficacy of the radiation-attenuated PfSPZ malaria vaccine
41. Immunoprofiles associated with controlled human malaria infection and naturally acquired immunity identify a shared IgA pre-erythrocytic immunoproteome
42. Clonal evolution and specificity of the human T follicular helper cell response toPlasmodium falciparumcircumsporozoite protein
43. Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial
44. Progress in Development of an Automated Mosquito Salivary Gland Extractor: A Step Forward to Malaria Vaccine Mass Production
45. Incidence of Plasmodium falciparum malaria infection in 6-month to 45-year-olds on selected areas of Bioko Island, Equatorial Guinea
46. Early whole blood transcriptional responses to radiation-attenuated Plasmodium falciparum sporozoite vaccination in malaria naïve and malaria pre-exposed adult volunteers
47. Knockout of Anopheles stephensi immune gene LRIM1 by CRISPR-Cas9 reveals its unexpected role in reproduction and vector competence
48. Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity
49. Transient knockdown of Anopheles stephensi LRIM1 using RNAi increases Plasmodium falciparum sporozoite salivary gland infections
50. Identification of the Glycan Binding Profile of Human and Rodent Plasmodium Sporozoites
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.